GNA13 promotes the proliferation and migration of lung squamous cell carcinoma cells through regulating the PI3K/AKT signaling pathway

Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

(2019) Satoru Senoo et al.   International Journal of Clinical Oncology

Alpelisib: First Global Approval

(2019) Anthony Markham   DRUGS

Targeting mTOR for cancer therapy

(2019) Hui Hua et al.   Journal of Hematology & Oncology

Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer

(2018) Mark A. Socinski et al.   Journal of Thoracic Oncology

GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-κB signaling pathway in colorectal cancer cells

(2018) Zhongqiang Zhang et al.   Cancer Medicine

Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy

(2017) Yu Zhang et al.   ENDOCRINE REVIEWS

GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers

(2017) Suhail Ahmed Kabeer Rasheed et al.   ONCOGENE

Analysis of GNA13 Protein in Follicular Lymphoma and its Association With Poor Prognosis

(2017) Joji Shimono et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: An emerging treatment strategy for squamous cell lung carcinoma

(2014) Joseph Thaddeus Beck et al.   CANCER TREATMENT REVIEWS

Ki67 is a promising molecular target in the diagnosis of cancer (Review)

(2014) LIAN TAO LI et al.   Molecular Medicine Reports

Targeting PI3K/Akt/mTOR Signaling in Cancer

(2014) Camillo Porta et al.   Frontiers in Oncology

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program

(2011) Karynsa Cetin et al.   Clinical Epidemiology